|
Analysis of cerebrospinal fluid of depressed patients
Marcus C Rosenhagen, Max Planck Institute of Psychiatry, Germany
|
|
Sub-chronic treatment effects of Jarsin (an extract of St John's wort) on evening salivary cortisol and melatonin in healthy male volunteers
Mike Franklin, University of Oxford, United Kingdom
|
|
Nutritional effects on the outcome of schizophrenia and the prevalence of depression
Malcolm Peet, Rotherham Mental Health Services, United Kingdom
|
|
Can people with schizophrenia improve their diet: A randomised controlled trial
Prof Robin G McCreadie, Crichton Royal Hospital, Dumfries, Scotland, United Kingdom
|
|
Seizure severity assessment with add-on Lamotrigine therapy
Ahmad Imam, Kharkiv Medical Academy of Postgraduate Education, Ukraine
|
|
A comparison of thalamic m1 and m4 muscarinic receptors in control subjects and subjects with schizophrenia
Laura Gray, The Mental Health Research Institute of Victoria, Australia
|
|
Xanthine oxidase activity is decreased in distinct brain areas of patients with schizophrenic psychoses - a post-mortem study
Dr Tanja M Michel, Institute for Clinical Neurochemistry, Universtity of Wuerzburg, Germany
|
|
Gene expression of Neurotrophin-3 and nerve growth factor in postmortem brain of suicide victims
Dr Yogesh Dwivedi, University of Illinois at Chicago, United States
|
|
The effect of excitative neurotoxins on free Ca2+ in brain cells in rat: Probable pathogenesis of Alzheimer's disease
Dr. Mr Bai Han, Shanxi Medical University, China
|
|
Glutamate uptake is significantly increased in the brain of the PUFA-deficient rat
Vladimir J Balcar, The University of Sydney, Australia
|